Survivors of torture presenting at an anxiety disorders clinic: symptomatology and pharmacotherapy.
Bouwer
C
C
Department of Psychological Medicine, University of Otago, Dunedin, New Zealand.
Stein
D J
DJ
D015057:1-Naphthylamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D015897:Comorbidity; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline; D013019:South Africa / Q000453:epidemiology; D017741:Survivors / Q000523:psychology*; D014104:Torture / Q000523:psychology*; D016896:Treatment Outcome
D015057:1-Naphthylamine; D000928:Antidepressive Agents; D007099:Imipramine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline